Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
899 studies found for:    Uterine Cancer: Clinical Trials
Show Display Options
Rank Status Study
21 Completed
Has Results
Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma
Conditions: Leiomyosarcoma;   Uterine Neoplasm
Intervention: Drug: gemcitabine, docetaxel, doxorubicin
22 Completed
Has Results
Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Cancer
Conditions: Recurrent Uterine Sarcoma;   Uterine Carcinosarcoma
Interventions: Drug: imatinib mesylate;   Other: laboratory biomarker analysis
23 Recruiting Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy
Conditions: Ovarian Cancer;   Peritoneal Cancer;   Fallopian Tube Cancer;   Uterine Cancer;   Mesotheliomas;   Gastrointestinal Cancers;   Cervical Cancer
Interventions: Device: HIPEC: MMC 30mg @ T0, 10mg @ T45min;   Device: HIPEC: MMC + CDDP 30mg @ T0, 10mg @ T45min 50 mg/m2 @T0;   Device: HIPEC: CDDP 75 mg/m2 @T0;   Device: HIPEC: CDDP+ Doxorubicin 50 mg/m2 @T0 15 mg/m2 @T0
24 Completed
Has Results
A Trial for Patients With Advanced/Recurrent Cervical Cancer
Conditions: Cervical Intraepithelial Neoplasia;   Uterine Neoplasms;   Genital Neoplasms, Female
Intervention: Drug: Pemetrexed
25 Completed Musicotherapy in the Reduction of Fatigue in Women With Breast or Gynecological Cancer Under Radiotherapy
Conditions: Breast Cancer;   Uterine Cancer;   Ovarian Cancer
Intervention: Behavioral: Music therapy
26 Recruiting Improving the Treatment for Women With Early Stage Cancer of the Uterus
Conditions: Complex Endometrial Hyperplasia With Atypia;   Grade 1 Endometrial Endometrioid Adenocarcinoma
Interventions: Drug: Levonorgestrel;   Drug: Metformin
27 Recruiting Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer
Conditions: Breast Carcinoma;   Endometrial Clear Cell Adenocarcinoma;   Endometrial Serous Adenocarcinoma;   Uterine Corpus Cancer;   Uterine Corpus Carcinosarcoma
Interventions: Drug: Metformin Hydrochloride;   Drug: Doxycycline
28 Recruiting A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
Conditions: Sexual Dysfunctions, Psychological;   Uterine Cervical Neoplasms;   Ovarian Neoplasms;   Uterine Neoplasms;   Genital Neoplasms, Female
Intervention: Behavioral: GyneGals Support Group
29 Completed A Trial for Patients With Gestational Trophoblastic Disease
Conditions: Trophoblastic Neoplasms;   Uterine Neoplasms;   Hydatidiform Mole;   Choriocarcinoma
Intervention: Drug: Pemetrexed
30 Not yet recruiting Clinical Trial of Laparoscopic Pelvic and Para-aortic Lymphadenectomy and Uterine Blood Vessel Blocking for Precision Diagnosis and Treatment in Advanced Cervical Cancer
Conditions: Cervical Cancer, Stage IIB;   Cervical Cancer Stage IIIA;   Cervical Cancer Stage IIIB;   Cervical Cancer, Stage IVA
Intervention:
31 Unknown  Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer
Conditions: Recurrent Uterine Sarcoma;   Uterine Carcinosarcoma
Interventions: Drug: ixabepilone;   Other: laboratory biomarker analysis
32 Completed Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer
Conditions: Recurrent Uterine Corpus Sarcoma;   Uterine Carcinosarcoma
Intervention: Drug: Pazopanib Hydrochloride
33 Terminated Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Conditions: Uterine Cervical Cancer;   Endometrial Cancer
Intervention: Drug: Zalypsis ( PM00104)
34 Completed Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer
Conditions: Recurrent Uterine Corpus Sarcoma;   Uterine Carcinosarcoma
Interventions: Drug: Gemcitabine Hydrochloride;   Drug: Docetaxel
35 Completed
Has Results
Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer
Conditions: Recurrent Uterine Sarcoma;   Stage III Uterine Sarcoma;   Stage IV Uterine Sarcoma;   Uterine Carcinosarcoma
Intervention: Drug: sorafenib tosylate
36 Withdrawn A Phase II Clinical Trial of Chemo-radiotherapy in Combination With INO-3112 in Patients With Locally Advanced Cervical Cancer
Condition: Uterine Cervical Neoplasms
Interventions: Biological: INO-3112 vaccine;   Radiation: Radiotherapy (Extrernal beam radiotherapy + brachytherapy);   Drug: Cisplatin chemotherapy
37 Recruiting Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates.
Conditions: Ovarian Cancer;   Cervical Cancer;   Uterine Cancer;   Anemia
Interventions: Other: Oral Ferrous Fumarate;   Other: Placebo
38 Active, not recruiting Image-Guided Gynecologic Brachytherapy
Conditions: Cervical Cancer;   Uterine Cancer;   Vaginal Cancer;   Carcinoma of the Vulva
Intervention: Procedure: Image-guided brachytherapy
39 Terminated Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus
Condition: Sarcoma
Intervention: Drug: paclitaxel
40 Terminated Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the Uterus
Condition: Sarcoma
Intervention: Drug: gemcitabine hydrochloride

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.